Zobrazeno 1 - 4
of 4
pro vyhledávání: '"FJ Maiques Llácer"'
Autor:
C Sangrador Pelluz, FJ Maiques Llácer, E Soler Company, P Taberner Bonastre, S García Muñoz, M Monzó Rausell
Publikováno v:
European Journal of Hospital Pharmacy. 21:A106.3-A107
Background Telaprevir is used in the treatment of chronic hepatitis C (HCV). Purpose To find out at what point adverse reactions (ADRs) appear from the start of telaprevir treatment in order to prevent harm and improve management. Materials and metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33ed71d43ecc694d2ac9faf545ac3365
https://doi.org/10.1136/ejhpharm-2013-000436.262
https://doi.org/10.1136/ejhpharm-2013-000436.262
Autor:
C Sangrador Pelluz, FJ Maiques Llácer, E Soler Company, JP Navarro Ferrando, P Taberner Bonastre, L Barrajón Pérez
Publikováno v:
European Journal of Hospital Pharmacy. 21:A107.1-A107
Background Telaprevir is a new drug for the treatment of chronic hepatitis C virus (HCV). Purpose To compare the safety of telaprevir treatment between HCV mono-infected patients and HIV co-infected patients. Materials and methods Retrospective obser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adba090e1b3b964cbcf33429e40435fa
https://doi.org/10.1136/ejhpharm-2013-000436.263
https://doi.org/10.1136/ejhpharm-2013-000436.263
Autor:
Sangrador Pelluz C; Servicio de Farmacia. Hospital Arnau de Vilanova. Valencia. España.. sangrador_cri@gva.es., Maiques Llácer FJ, Soler Company E
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2014 Jan 01; Vol. 38 (1), pp. 25-9. Date of Electronic Publication: 2014 Jan 01.
Autor:
Sangrador Pelluz C; Servicio de Farmacia. Hospital Arnau de Vilanova. Valencia. España., Maiques Llácer FJ, Soler Company E
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2013 Nov-Dec; Vol. 37 (6), pp. 489-93.